Evidence map›Paper›PMID 35317884›Full record

ArticleEpidemiology and infection2022

Increased transmission of SARS-CoV-2 in Denmark during UEFA European championships.

Marc Bennedbæk, Mia Sarah Fischer Button, Lise Birk Nielsen, Jonas Bybjerg-Grauholm, Christina Wiid Svarrer, Karina Lauenborg Møller, Brian Kristensen, Rebecca Legarth, Vithiagaran Gunalan, Ditte Rechter Zenas and 9 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marc BennedbækVirus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Mia Sarah Fischer ButtonDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Lise Birk NielsenDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Jonas Bybjerg-GrauholmDepartment for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0003-1705-4008
Christina Wiid SvarrerDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Karina Lauenborg MøllerDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Brian KristensenDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Rebecca LegarthDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Vithiagaran GunalanVirus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Ditte Rechter ZenasDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Irfatha IrshadDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Sophie GubbelsDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Raphael N SieberDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Marc SteggerDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Palle Valentiner-BranthDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Morten RasmussenVirus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Camilla Holten MøllerDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
Jannik FonagerVirus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Frederik Trier MollerDivision of Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-1059-4661

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Denmark hosted four games during the 2020 UEFA European championships (EC2020). After declining positive SARS-CoV-2 test rates in Denmark, a rise occurred during and after the tournament, concomitant with the replacement of the dominant Alpha lineage (B.1.1.7) by the Delta lineage (B.1.617.2), increasing vaccination rates and cessation of several restrictions. A cohort study including 33 227 cases was conducted from 30 May to 25 July 2021, 14 days before and after the EC2020. Included was a nested cohort with event information from big-screen events and matches at the Danish national stadium, Parken (DNSP) in Copenhagen, held from 12 June to 28 June 2021. Information from whole-genome sequencing, contact tracing and Danish registries was collected. Case-case connections were used to establish transmission trees. Cases infected on match days were compared to cases not infected on match days as a reference. The crude incidence rate ratio (IRR) of transmissions was 1.55, corresponding to 584 (1.76%) cases attributable to EC2020 celebrations. The IRR adjusted for covariates was lower (IRR 1.41) but still significant, and also pointed to a reduced number of transmissions from fully vaccinated cases (IRR 0.59). These data support the hypothesis that the EC2020 celebrations contributed to the rise of cases in Denmark in the early summer of 2021.

Indexed as

COVID-19SARS-CoV-2Cohort StudiesDenmarkHumansEpidemiologymass eventspublic healthSARS-CoV-2transmission

Identifiers

PMID35317884
PMCPMC9254153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.